Tonix Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Programs Update

Go back to Tonix Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Programs Update

Tonix Pharmaceuticals (TNXP) Reports Q2 Loss of $0.50/Share

August 8, 2016 7:20 AM EDT

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q2 EPS of ($0.50), versus ($0.73) reported last year.

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

... More